Medication-Assisted Treatment for opioid use disorder.
MAT is the clinical standard of care for opioid use disorder. Suboxone, methadone, Vivitrol, and naltrexone are all typically covered by Kentucky Medicaid plans and reduce overdose mortality by more than half when continued long-term.
Kentucky Medicaid plans typically cover MAT.
Kentucky Medicaid plans typically cover Suboxone, Subutex, methadone, Vivitrol, and oral naltrexone for opioid use disorder. Pick your plan to see specific formulations, authorization, and pharmacy benefit details.
Coverage is determined by medical necessity. Call admissions and we'll verify your specific plan as part of the call.
Medications used in opioid treatment for opioid use disorder.
Golden Grove will offer Suboxone, Subutex and Vivitrol. Methadone is dispensed only at a federally licensed Opioid Treatment Program, not at Golden Grove.
Suboxone
Buprenorphine + naloxone. Office-based daily sublingual dosing. Partial agonist with built-in misuse deterrent.
Learn more about Suboxone →Subutex
Buprenorphine alone. Used during pregnancy when the naloxone in Suboxone isn't appropriate.
Learn more about Subutex →Methadone
Full opioid agonist. Daily on-site dosing at a federally licensed Opioid Treatment Program (OTP).
Learn more about Methadone →Vivitrol
Extended-release naltrexone. Monthly injection. Requires 7–14 days opioid-free before the first dose.
Learn more about Vivitrol →Oral naltrexone
Daily oral antagonist. Pill form of the same medication as Vivitrol. Lower adherence than injection.
Common questions about MAT.
Will my Kentucky Medicaid plan cover MAT?
Yes. Kentucky Medicaid plans typically cover MAT for opioid use disorder. Pharmacy prior authorization may apply to specific formulations.
Which MAT is right for me?
It depends on overdose risk, prior treatment history, pregnancy status, ability to attend daily dosing (for methadone), and personal preference. A Golden Grove clinician will help you choose during the assessment.
Can I do MAT during pregnancy?
Yes. Subutex (buprenorphine alone, without naloxone) is the standard MAT for pregnant members with OUD, and is typically covered by Kentucky Medicaid plans. Methadone in an OTP is also a coverage option.
How long should I stay on MAT?
MAT is meant to be a long-term treatment for many patients. There is no fixed duration for MAT. How long someone stays on it is a clinical decision. Tapering, when appropriate, should be gradual and clinically guided.
Verify your MAT coverage and start treatment.
Admissions answers 24/7. Golden Grove will accept Kentucky Medicaid. Coverage check happens on the call.